课题基金 / 基金详情

Defining the Mechanisms by Which Mutations in DNAJC7 Increase Susceptibility to ALS/FTD

Defining the Mechanisms by Which Mutations in DNAJC7 Increase Susceptibility to ALS/FTD
确定 DNAJC7 突变增加 ALS/FTD 易感性的机制
批准号:
10645510
负责人:
Evangelos Kiskinis
金额:
$23.04万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
已结题
起止时间:
2023-01-18 至 2024-12-31

项目摘要

项目成果

Evangelos Kiskinis的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The accumulation of insoluble and misfolded proteins is commonly associated with degeneration of neurons in amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) patients. Heat shock proteins (HSPs) play a central role in the regulation of protein homeostasis by facilitating effective folding, trafficking, and degradation of both nascent and aged polypeptides. While it has become increasingly clear that perturbations in in the proteostasis network play a significant role in ALS/FTD, limited emphasis has been placed on investigating the direct causal relationship between the functionality of HSPs and disease pathogenesis. Heterozygous, loss- of-function mutations in the DNAJC7 gene, which encodes for the HSP40 protein DNAJC7 have recently been identified as a cause for rare forms of ALS. The DNAJC7 protein acts as a co-chaperone for HSP70 chaperones, thereby facilitating HSP70-polypeptide interactions and appropriate polypeptide folding. However, little is known about the specific function of DNAJC7 in the central nervous system and motor neurons specifically, the cell type that predominantly degenerates in ALS patients. Our primary hypothesis is that DNAJC7 haploinsufficiency leads to the accumulation of misfolded HSP70 client proteins resulting in the disruption of biological processes critical to the function and survival of vulnerable MNs. Here, we will use mutant DNAJC7 cellular models, patient induced pluripotent stem cell (iPSC)-derived cortical and spinal motor neurons and CRISPR/Cas9 gene-editing, in combination with mass spectrometry (MS)-based quantitative proteomics and RNA-Sequencing to elucidate how ALS/FTD-associated mutations in DNAJC7 contribute towards neuronal dysfunction and degeneration. In Aim 1 we will determine the endogenous interactome of DNAJC7 in mutant and isogenic control human neurons to better understand the functional role that it plays in postmitotic cells. In Aim 2 we will methodically characterize disruptions in protein folding caused by pathogenic DNAJC7 using two independent MS-based proteomics approaches. These experiments will provide an unbiased proteome-wide interrogation of fundamental aspects of proteostasis in ALS-DNAJC7 mutant and isogenic control neurons. In Aim 3, which is based on our preliminary finding that DNAJC7 interacts with the ALS-casual RNA-metabolism proteins FUS and MATR3, we will investigate how DNAJC7 mutations affect RNA processing in patient neurons. Taken together, our proposed aims will shed light upon the cellular mechanisms that are compromised by DNAJC7 haploinsufficiency in distinct human cortical and spinal neurons. Our findings will impact the field by contributing towards the understanding of HSP-dependent proteostasis mechanisms in human neurons as well as to how rare ALS genetic mutations lead to neuron dysfunction and loss. Identifying novel proteins that are susceptible to misfolding in human neurons might highlight cellular pathways critical for ALS/FTD pathophysiology.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Investigating the Contribution of ALS/FTD-Associated Mutations in the NEK1 Kinase to Disease Pathophysiology
Defining The Impaired Proteostasis Network in ALS Patient Motor Neurons
Project 2 - Investigation of human neuron models of channelopathy-associated epilepsy
Determining How Defective Nucleo-Cytoplasmic Trafficking Leads To Neurodegeneration In C9orf72-Related ALS And FTD
海外基金